Integrated Biosciences

Integrated Biosciences leverages synthetic biology and machine learning to develop drugs targeting cellular stress responses, which contribute to age-related diseases like neurodegeneration, cancer, and diabetes. Their proprietary technology enables the discovery of small-molecule therapeutics that can modify disease progression and promote healthy aging. By virtually activating cellular stress responses, they rapidly identify new drug targets, pushing the boundaries of longevity science and therapeutic development.